Chemical Structure (Propofol 01)
Not available.*
Propofol Injection, Emulsion
Product Images NDC 0409-4699
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Propofol (NDC 0409-4699). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Graph (Propofol 02)
Hospira Logo (Propofol 03)
Principal Display Panel (20 mL Vial Label)
This is a description of a medication labeled as Reonly NDC0405-4659-50. This medication is supplied in a 20 mL container for single patient use only. It is an injectable emulsion that contains propofol 10mg, soybean oil 100mg, glycerin 22.5mg, egglecithin12 mg, benzyl alcohol 1.5 mg, and sodium benzoate 0.7 mg. It is nonpyrogenic and its pH is adjusted with sodium hydroxide. The dosing information is available in the package insert. The medication should be shaken well before use and it is for intravenous administration only.*
Principal Display Panel (20 mL Vial Carton)
This is a description of a drug named Propofol that comes in a 5x20mL vial and contains benzyl alcohol which inhibits microbial growth. It is an injectable emulsion and should only be used by a single patient. The drug should be discarded within 12 hours of opening. It is used as an anesthetic to maintain patent airway and artificial ventilation. There are precautions to be taken during administration, including strict aseptic technique procedures. Not available for what specific condition it is used for.*
Principal Display Panel (50 mL Vial Label)
This text is a description of a medication called "PRCPOFOL" which is an injectable emulsion and has a concentration of 500mg/50 ml (10mg/mL). It is meant to be used for single patient use only and requires the use of strict aseptic technique during administration. It contains propofol, soybean oil, glycerin, egg lecithin and benzyl alcohol among other ingredients. The medication is distributed by Hospira, Inc. in Lake Forest, USA, and should be shaken well before use. The text also provides some regulatory and compliance information such as an AP/DRUGS code and an NDC number.*
Principal Display Panel (50 mL Vial Tray)
This is a description of a drug named Propofol, which is an injectable emulsion containing 500mg/50mL or 10mg/mL. It's unknown if it's being sold or stored. It is to be administered by someone trained in the administration of general anesthesia or involved in the conduct of surgical/diagnostic procedures. It is only for prescription use. The text also mentions that it contains Benzyl Alcohol, which inhibits microbial growth up to 12 hours. The rest of the text is not in English and cannot be evaluated.*
Propofol 08
This is a description of a medical product called Propofol, which is an injectable emulsion used for intravenous administration. It comes in a 20mL single-use vial, and it's important to discard it within 12 hours of opening due to possible microbial growth. The emulsion contains 200mg/20mL (10mg/mL) of propofol, and other ingredients like soybean oil, glycerin, benzyl alcohol, and sodium benzoate. It is not intended for freezing, and should be stored at 20-25°C. The dosage should be determined based on the package insert.*
Propofol 09
This is a description of a medication called Propofol, an injectable emulsion used as an aseptic product. It comes in 200mg/20ml containers and should be used for intravenous administration. It contains benzyl alcohol and should not be frozen. The medication should be shaken well before use. The rest of the text consists of unclear characters and is not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
